Renal diseases shall be diagnosed earlier and treated more successfully in the future. Towards this aim, researchers from nine European countries*, coordinated by the Max DelbrÃ ck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have been working for the past four-and-a half years to create a three-dimensional virtual "Kidney Atlas". It incorporates the latest research findings on the development and diseases of the kidney. The Kidney Atlas was part of the European Renal Genome Project (EuReGene), which the European Union (EU) funded with more than 10 million euros. At the conclusion of the project, the Kidney Atlas was presented at MDC during a two-day symposium from May 15-16, 2009, which was attended by approximately 100 researchers.
The fastest-growing group of patients initiating dialysis is patients 75 years old and older; providing the best care for this group of patients presents significant challenges. The American Society of Nephrology (ASN) introduces the first-ever online curriculum to address aging and the kidney. The curriculum, based on the Accreditation Council for Graduate Medical Education (ACGME)'s six core competences of patient care, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, professionalism, and systems-based practice, answers questions about the management of elderly patients. Twenty-five percent of institutions with accredited US nephrology training programs do not have accredited geriatric training programs, but the Accreditation Council for Graduate Medical Education (ACGME) has mandated that fellows receive formal training in geriatric nephrology.
Inventors Develop Novel Technique To Help Customize, Enhance The Effectiveness Of Bladder Cancer Treatment
Researchers in the University of Virginia Department of Urology have developed a novel method that could help physicians determine the best course of treatment for patients suffering from bladder cancer. Bladder cancer is typically treated by neoadjuvant chemotherapy, a treatment in which chemotherapy is administered to reduce the size of the cancer prior to surgery, with the two most commonly used chemotherapeutic regimens being M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and GemCis (gemcitabine and cisplatin). While M-VAC has long been considered the more potent regimen and is often offered as the gold standard for treatment, it is quite toxic and known to successfully treat only about 25 percent of patients who receive it.
UroToday.com - In the Lancet Oncology online edition, Dr. Andrew Vickers and collaborators report that prostate cancer (CaP) recurrence is significantly reduced with increasing surgical experience among urologists performing laparoscopic radical prostatectomy (LRP). The learning curve appears greater than that for open radical prostatectomy. In open RP analysis, the probability of a cancer recurrence decreased after 250-350 cases. In this multicenter, international retrospective cohort all patients had LRP without use of robotic assistance. A total of 4, 702 patients treated between 1998 and 2007 were eligible for analysis. These patients were treated by one of 29 surgeons with 250 by 5 surgeons (17%).
UroToday.com - Robotic and medical imaging technology has made leaps and bounds over the past few decades, and the practice of brachytherapy should take advantage of these advances. Of course, any new technology cannot be implemented in the clinic without a scientifically validated foundation, which must be established in order to justify the move away from tried-and-true methods. With this in mind, we present this paper as a peek into the future -- alternative, potentially useful implant catheter patterns. Brachytherapy places concentrated sources of radiation inside the body inside cancerous tissues and organs using an external template of fixed positions to help the physician guide the insertion needles or catheters.
SCRIP's 'Best-In-Class' Reporting Recognised By Industry - Journalist Malani Guha Wins Advances In Renal Cancer Journalists' Award
Journalist, Malini Guha, has won the prestigious new Advances in Renal Cancer Journalists' Award - Europe for her article "New Advances Deliver Fresh Hope in Kidney Cancer" - which was published in Scrip World Pharmaceutical News on February 13th 2009. The award was presented by the esteemed Association of German Medical Journalists (VDMJ) at this month's Fourth European International Kidney Cancer Symposium in Berlin. In her article, Malini Guha - Science Editor at Scrip - provides a concise and informative review of the current options and prospects of success in the treatment of renal cell carcinoma. "It is a great honour to be the first-ever recipient of this award, " says Malini.